Rolofylline
Rolofylline (KW-3902) is a potent, selective adenosine A1 receptor antagonist that is under development for the treatment of patients with acute congestive heart failure and renal impairment. Rolofylline is metabolized primarily to the pharmacologically active M1-trans and M1-cis metabolites by cytochrome P450 (CYP450) [1]. Rolofylline is alleviating the presynaptic dysfunction and restores neuronal activity as well as dendritic spine levels in vitro, is an interesting candidate to combat the hypometabolism and neuronal dysfunction associated with Tau-induced neurodegenerative diseases[2].
Product Specifications
CAS Number
136199-02-5
Product Name Alternative
KW-3902
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Adenosine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/rolofylline.html
Purity
99.68
Solubility
DMSO : 20 mg/mL (ultrasonic)
Smiles
O=C(N1CCC)N(CCC)C2=C(N=C(C34CC(C5)CC3CC5C4)N2)C1=O
Molecular Formula
C20H28N4O2
Molecular Weight
356.46
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GD3 Synthase Lentiviral Activation Particles (h)
Protein Phosphatase 2, Control Peptide (formerly 2A) (Catalytic Subunit alpha/beta, PP2A alpha, PP2A-A, PP2C alpha, PP2CA, PPP2CA, PP2A beta, PP2A-B, PP2C beta, PP2CB, PPP2CB, PP2Ac, Replication Protein C, RP-C, PPP2R3, PR130, PR72, PPP2R3A) discontinued
PCDHB4 (NM_018938) Human Over-expression Lysate
5-Methyl-5H,6H,7H,8H-imidazo[1,2-a]pyridine-3-carboxylic acid hydrochloride
5-Methyl-5H,6H,7H,8H-imidazo[1,2-a]pyridine-3-carboxylic acid hydrochloride
